Teneligliptin in management of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Teneligliptin in management of type 2 diabetes mellitus

Published:2016-08 Issue: Volume:Volume 9 Page:251-260
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Swami Onkar,Sharma Surendra Kumar,Panneerselvam A.,Singh Kiran Pal,Parmar Girish,Gadge Pradeep

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?;World Journal of Diabetes;2024-09-15

2. Teneligliptin: A potential therapeutic approach for diabetic cardiomyopathy;World Journal of Diabetes;2024-08-15

3. Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial;Perspectives in Clinical Research;2024-07-10

4. Development and Validation of Fast and Sensitive RP-HPLC Stability Indicating Method for Quantification of Teneligliptin in Bulk Drug;J CHROMATOGR SCI;2024

5. Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: design, synthesis, biological evaluation, and molecular docking study;Molecular Diversity;2024-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP